245 related articles for article (PubMed ID: 32150977)
1. Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas.
Sarkadi B; Meszaros K; Krencz I; Canu L; Krokker L; Zakarias S; Barna G; Sebestyen A; Papay J; Hujber Z; Butz H; Darvasi O; Igaz P; Doczi J; Luconi M; Chinopoulos C; Patocs A
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32150977
[TBL] [Abstract][Full Text] [Related]
2. Analysis of SDHAF3 in familial and sporadic pheochromocytoma and paraganglioma.
Dwight T; Na U; Kim E; Zhu Y; Richardson AL; Robinson BG; Tucker KM; Gill AJ; Benn DE; Clifton-Bligh RJ; Winge DR
BMC Cancer; 2017 Jul; 17(1):497. PubMed ID: 28738844
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation.
Kamai T; Murakami S; Arai K; Nishihara D; Uematsu T; Ishida K; Kijima T
BMC Cancer; 2022 Mar; 22(1):289. PubMed ID: 35300626
[TBL] [Abstract][Full Text] [Related]
5. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
Gill AJ
Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
[TBL] [Abstract][Full Text] [Related]
6. Novel SDHB and TMEM127 Mutations in Patients with Pheochromocytoma/Paraganglioma Syndrome.
Patócs A; Lendvai NK; Butz H; Liko I; Sapi Z; Szucs N; Toth G; Grolmusz VK; Igaz P; Toth M; Rácz K
Pathol Oncol Res; 2016 Oct; 22(4):673-9. PubMed ID: 26960314
[TBL] [Abstract][Full Text] [Related]
7. SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T).
Papathomas TG; Oudijk L; Persu A; Gill AJ; van Nederveen F; Tischler AS; Tissier F; Volante M; Matias-Guiu X; Smid M; Favier J; Rapizzi E; Libe R; Currás-Freixes M; Aydin S; Huynh T; Lichtenauer U; van Berkel A; Canu L; Domingues R; Clifton-Bligh RJ; Bialas M; Vikkula M; Baretton G; Papotti M; Nesi G; Badoual C; Pacak K; Eisenhofer G; Timmers HJ; Beuschlein F; Bertherat J; Mannelli M; Robledo M; Gimenez-Roqueplo AP; Dinjens WN; Korpershoek E; de Krijger RR
Mod Pathol; 2015 Jun; 28(6):807-21. PubMed ID: 25720320
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional consequences of succinate dehydrogenase subunit B mutations.
Kim E; Rath EM; Tsang VH; Duff AP; Robinson BG; Church WB; Benn DE; Dwight T; Clifton-Bligh RJ
Endocr Relat Cancer; 2015 Jun; 22(3):387-97. PubMed ID: 25972245
[TBL] [Abstract][Full Text] [Related]
9. Primary fibroblast co-culture stimulates growth and metabolism in Sdhb-impaired mouse pheochromocytoma MTT cells.
Richter S; D'Antongiovanni V; Martinelli S; Bechmann N; Riverso M; Poitz DM; Pacak K; Eisenhofer G; Mannelli M; Rapizzi E
Cell Tissue Res; 2018 Dec; 374(3):473-485. PubMed ID: 30159755
[TBL] [Abstract][Full Text] [Related]
10. Identification of succinate dehydrogenase-deficient bladder paragangliomas.
Mason EF; Sadow PM; Wagner AJ; Remillard SP; Flood TA; Belanger EC; Hornick JL; Barletta JA
Am J Surg Pathol; 2013 Oct; 37(10):1612-8. PubMed ID: 23797725
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of negative and weak-diffuse pattern of SDHB immunostaining in assessment of SDH mutations in paragangliomas and pheochromocytomas.
Castelblanco E; Santacana M; Valls J; de Cubas A; Cascón A; Robledo M; Matias-Guiu X
Endocr Pathol; 2013 Dec; 24(4):199-205. PubMed ID: 24096807
[TBL] [Abstract][Full Text] [Related]
12. The aggressiveness of succinate dehydrogenase subunit B-deficient chromaffin cells is reduced when their bioelectrical properties are restored by glibenclamide.
Amore F; Garella R; Santi A; Guasti D; Martinelli S; Canu L; Bani D; Neuzil J; Maggi M; Squecco R; Rapizzi E
Endocr Relat Cancer; 2023 Oct; 30(10):. PubMed ID: 37493200
[TBL] [Abstract][Full Text] [Related]
13. Increased SSTR2A and SSTR3 expression in succinate dehydrogenase-deficient pheochromocytomas and paragangliomas.
Elston MS; Meyer-Rochow GY; Conaglen HM; Clarkson A; Clifton-Bligh RJ; Conaglen JV; Gill AJ
Hum Pathol; 2015 Mar; 46(3):390-6. PubMed ID: 25554089
[TBL] [Abstract][Full Text] [Related]
14. Tumour microenvironment in pheochromocytoma and paraganglioma.
Martinelli S; Amore F; Canu L; Maggi M; Rapizzi E
Front Endocrinol (Lausanne); 2023; 14():1137456. PubMed ID: 37033265
[TBL] [Abstract][Full Text] [Related]
15. Succinate dehydrogenase (SDH)-deficient neoplasia.
Gill AJ
Histopathology; 2018 Jan; 72(1):106-116. PubMed ID: 29239034
[TBL] [Abstract][Full Text] [Related]
16. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA
Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318
[TBL] [Abstract][Full Text] [Related]
17. Targeting pheochromocytoma/paraganglioma with polyamine inhibitors.
Rai SK; Bril F; Hatch HM; Xu Y; Shelton L; Kalavalapalli S; Click A; Lee D; Beecher C; Kirby A; Kong K; Trevino J; Jha A; Jatav S; Kriti K; Luthra S; Garrett TJ; Guingab-Cagmat J; Plant D; Bose P; Cusi K; Hromas RA; Tischler AS; Powers JF; Gupta P; Bibb J; Beuschlein F; Robledo M; Calsina B; Timmers H; Taieb D; Kroiss M; Richter S; Langton K; Eisenhofer G; Bergeron R; Pacak K; Tevosian SG; Ghayee HK
Metabolism; 2020 Sep; 110():154297. PubMed ID: 32562798
[TBL] [Abstract][Full Text] [Related]
18. Yeast model for evaluating the pathogenic significance of SDHB, SDHC and SDHD mutations in PHEO-PGL syndrome.
Panizza E; Ercolino T; Mori L; Rapizzi E; Castellano M; Opocher G; Ferrero I; Neumann HP; Mannelli M; Goffrini P
Hum Mol Genet; 2013 Feb; 22(4):804-15. PubMed ID: 23175444
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of chromogranin A in SDHx-related paragangliomas.
Zuber S; Wesley R; Prodanov T; Eisenhofer G; Pacak K; Kantorovich V
Eur J Clin Invest; 2014 Apr; 44(4):365-71. PubMed ID: 24467715
[TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.
van Nederveen FH; Gaal J; Favier J; Korpershoek E; Oldenburg RA; de Bruyn EM; Sleddens HF; Derkx P; Rivière J; Dannenberg H; Petri BJ; Komminoth P; Pacak K; Hop WC; Pollard PJ; Mannelli M; Bayley JP; Perren A; Niemann S; Verhofstad AA; de Bruïne AP; Maher ER; Tissier F; Méatchi T; Badoual C; Bertherat J; Amar L; Alataki D; Van Marck E; Ferrau F; François J; de Herder WW; Peeters MP; van Linge A; Lenders JW; Gimenez-Roqueplo AP; de Krijger RR; Dinjens WN
Lancet Oncol; 2009 Aug; 10(8):764-71. PubMed ID: 19576851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
